Overview

Thorough QT (TQT) Study to Evaluate the Effect of LC350189 on Cardiac Repolarization in Healthy Male and Female Subjects

Status:
Not yet recruiting

Trial end date:
2021-12-30

Target enrollment:

Participant gender:

Summary

This is a Phase 1, single-center, randomized, partially double-blind, placebo- and positive controlled, 4-way crossover study to evaluate the effect of a therapeutic and a supratherapeutic dose of LC350189 on the QTcF in healthy male and female subjects.

Phase:

Early Phase 1

Details

Lead Sponsor:

LG Chem

Treatments:

Moxifloxacin